Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-25 @ 5:36 PM
Study NCT ID:
NCT02819804
Status:
TERMINATED
Last Update Posted:
2020-02-11
First Post:
2016-06-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sponsor:
Northwestern University